3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma
1
Interventions
pembrolizumab
602
Cyclophosphamide
545
Magnetic Resonance Spectroscopy
524
Radiotherapy
513
Specimen Handling
506
Nivolumab
412
Cisplatin
380
Carboplatin
368
Biopsy
306
Blood Specimen Collection
302
Radiosurgery
290
Paclitaxel
280
Surveys and Questionnaires
270
Gemcitabine
270
Standard of Care
267
Drug Therapy
263
Dexamethasone
263
fludarabine
262
Bevacizumab
253
venetoclax
251
Oxaliplatin
209
Capecitabine
201
Rituximab
198
Radiation
192
Fluorouracil
189
Ipilimumab
188
durvalumab
184
Doxorubicin
179
Etoposide
176
atezolizumab
175
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Analgesics
×
1 year
×
Clear all
NCT06348719
2025-09-15
ROBOT-ECO-GYN
Rennes University Hospital
Phase NA
Recruiting
1,680 enrolled